HOME : SITEMAP
Home About Contact
Current Action Sections
  • Current Actions Home
  • Technology Class Actions
  • Insurance Actions
  • Tobacco Class Actions
  • Securities Actions
  • Pharmaceuticals
  • Other Categories





  • class action lawsuits

    SECURITIES
    CLASS ACTION LAWSUITS


    Class Action Lawsuits and Filings in the Securities Sector.

    Blockbuster Class Action

    Stanford Law School
    According to a press release dated November 10, 2005, the complaint alleges that Viacom was Blockbuster's controlling shareholder and that, prior to the Exchange Offer, Viacom caused Blockbuster to pay a $5 per share special dividend of which Viacom was the primary beneficiary. In order to pay the dividend, Blockbuster was forced to take on debt in the amount of approximately $1.1 billion.
    Full Story


    HCA, Inc.

    Several purported shareholder class action lawsuits have been filed against HCA and certain of its officers and directors with violations of the Securities Exchange Act of 1934. HCA is the nation's largest chain of for-profit hospitals. Specifically, the complaint alleges that during the Class Period, defendants caused HCA's shares to trade at artificially inflated prices by issuing false statements concerning the Company's purported financial successes while concealing that HCA's operational metrics had substantially deteriorated. Defendants' positive statements had their intended effect, inflating the Company's stock price by almost 50% from less than $40 per share on January 11, 2005 to its Class Period high of over $58 per share on June 22, 2005, during which time defendants sold almost 1 million shares of the Company's stock at inflated prices, pocketing more than $48 million in proceeds.
    Full Story


    Guidant Corporation

    According to a press release dated November 4, 2005, the complaint alleges that Guidant and certain of its officers and directors violated provisions of the Securities Exchange Act of 1934, causing the Company's stock price to become artificially inflated. On December 15, 2004, Guidant entered into a $24.5 billion merger deal with Johnson & Johnson . According to the complaint, while the Company pointed to its defibrillator business as a key component of that deal, it concealed from investors significant unaddressed product defect and liability issues of the Company's implantable defibrillator product lines.
    Full Story


    Class Action Lawsuit Against Cray, Inc.

    The Complaint alleges that defendants violated federal securities laws by issuing a series of material misrepresentations to the market during the Class Period concerning the Company's operations and prospects, thereby artificially inflating the price of Cray securities.
    Full Story



    Last Class Action Pages: Home : Other